Remembering to take medicine can be troublesome to those with memory loss, or for caregiver’s with busy schedules. For those with conditions such as Schizophrenia medical adherence is only possible with the help of a caregiver or tools such as pillboxes.
WHO reported that in 2003 only 50% of patients suffering from chronic diseases correctly take their medication. The low percentage of adherence among patients has created a new market for medical tools to increase this figure.
CB Insights reported that a digital pill from Proteus and Otsuka called “Abilify MyCite” was recently approved by the FDA. The pill has a sensor that communicates vitals from a patient. This allows caregivers to monitor a patient's vital signs and medication intake digitally.
According to the creators of Abilify MyCite caregivers can use the MYCITE phone application to review the patient's information and medication ingestion at anytime. Permission can be granted to only certain individual so the patient’s information is always confidential. This breakthrough in medication adherence will help caregiver's ensure that their patients are receiving their medication correctly.
Currently Abilify MyCite is mainly used to treat conditions such as schizophrenia, but the new ability to track how medication is ingested can possibly be used with other medications. Possibly in the future, Abilify MyCite can help seniors with Alzheimer adhere to their medication.